Advanced Therapies.
Thoughtfully Applied.
Some patients may benefit from advanced regenerative, longevity, recovery, or performance-focused therapies as part of a broader physician-guided strategy. These options are not appropriate for everyone and are never considered in isolation.
The Schreiber Precision Method emphasizes evaluation, timing, sequencing, and biological readiness before determining whether advanced interventions should be considered.
Advanced Therapies Are Tools.
Not the Strategy.
Regenerative and longevity-focused therapies may have a role in selected patients, but they should not be used simply because they are available. The more important question is whether they are appropriate, properly timed, and part of a coherent physician-guided plan.
Not for Everyone
Advanced therapies are considered only after clinical context, goals, risks, readiness, and appropriateness are reviewed.
Not Always First
Foundational issues such as sleep, metabolic health, hormones, inflammation, recovery, nutrition, and resilience may need to be addressed before advanced options make sense.
Not in Isolation
TPE, regenerative therapies, NAD pathway support, IV therapies, and related interventions are best considered within a broader clinical strategy.
The goal is not to determine what someone can receive. The goal is to determine what is appropriate.
Advanced Options May Be Considered When Appropriate.
Depending on a patient's goals, findings, clinical circumstances, and overall strategy, advanced therapies may be considered as part of a broader physician-guided approach. The specific options discussed below are examples of therapies that may be evaluated in appropriate situations.
Certain regenerative therapies may be subject to federal and state regulatory requirements. Where applicable, therapies are considered only when clinically appropriate, legally permissible, and consistent with applicable laws and regulations, including Florida Senate Bill 1768 and Florida Statutes §458.3245 and §459.0127 where applicable.
Therapeutic Plasma Exchange (TPE)
Therapeutic Plasma Exchange is an advanced medical procedure involving selective plasma removal and replacement. In appropriate circumstances, it may be considered as part of a broader physician-guided strategy involving inflammation, immune signaling, resilience, toxicant burden, and longevity-focused optimization.
Stem Cell-Based Therapies
Certain stem cell-based therapies may be considered in selected circumstances when clinically appropriate, legally permissible, and consistent with physician evaluation, treatment goals, and applicable regulatory requirements. Availability may vary based upon individual circumstances and governing laws.
Exosome-Based Therapies
Cell-signaling therapies may be considered in select circumstances as part of a comprehensive regenerative strategy, when legally permissible and following individualized physician review.
NAD Pathway Support
Approaches designed to support cellular energy metabolism, mitochondrial function, recovery, resilience, and healthy aging when clinically appropriate.
IV Nutrient Therapies
Targeted nutrient support strategies that may be utilized selectively based on individual needs, findings, and clinical objectives.
Glutathione & Antioxidant Support
Strategies focused on oxidative stress, recovery, cellular protection, and overall physiologic resilience.
Certain regenerative and stem cell therapies discussed on this website may be subject to federal and state regulatory requirements and may not be available or appropriate for every individual. Where applicable, such therapies are considered only when legally permissible, clinically appropriate, and consistent with applicable laws and regulations, including Florida Senate Bill 1768 and Florida Statutes §458.3245 and §459.0127 where applicable. Recommendations are individualized and may require additional clinical review, informed consent, and eligibility determination.
Certain advanced therapies may involve in-office procedures coordinated through the Werde-Schreiber practice in Surfside. Availability, appropriateness, and treatment recommendations are determined individually following physician evaluation.
The Therapy Matters.
The Evaluation Matters More.
Many clinics begin with a treatment. The Schreiber Precision Method begins with understanding the person. Before considering advanced therapies, we seek to understand goals, contributors, risks, readiness, competing priorities, and how a recommendation fits within the broader clinical picture.
Timing
A therapy may be appropriate eventually but not necessarily today. Biological readiness, foundational health, and competing priorities matter.
Sequencing
The question is not simply what should be done. The question is what should be done first, what should wait, and what should be combined.
Personalization
The same therapy may have very different relevance for two people with different goals, histories, findings, and circumstances.
Whether considering Therapeutic Plasma Exchange, regenerative therapies, stem cell-based therapies, exosome-based therapies, NAD pathway support, IV nutrient therapies, or other advanced interventions, the question is not simply what can be done.
The more important question is what is appropriate, when it should be considered, and whether it fits within the broader clinical strategy.
Advanced Care Requires Careful Standards.
When advanced therapies, peptides, prescribed nutraceuticals, or regenerative options are considered, quality, sourcing, appropriateness, and oversight matter. The Schreiber Precision Method does not treat these interventions as commodities.
Peptide Standards
When peptides are considered, Schreiber Precision Medicine prioritizes human-use compounding pharmacies and does not rely on research-use products intended for non-clinical use.
Prescribed Nutraceuticals
Nutraceutical recommendations may include physician-directed formulations selected or compounded specifically for the patient, based on clinical evaluation and laboratory findings when appropriate.
Regenerative Standards
Regenerative and biologic therapies are considered only when clinically appropriate, legally permissible, and consistent with applicable quality, sourcing, consent, and physician-review requirements.
The Source Matters
In advanced optimization, the question is not only whether an intervention may be useful. It also matters where it comes from, how it is prepared, whether it is appropriate for clinical use, whether it fits the patient’s situation, and whether it belongs in the treatment sequence.
Advanced interventions require more than access. They require judgment.
Determine What Is Appropriate
Before Deciding What To Do.
Advanced therapies can be powerful tools when they are appropriate for the individual, introduced at the right time, and integrated into a broader physician-guided strategy.
The first step is not selecting a treatment. The first step is understanding your goals, concerns, health history, and the factors that may be influencing your health, performance, recovery, resilience, or longevity.
Start Your Assessment